LabCompass

Kaitlin Annunzio

Medicine · The Ohio State University

OpenAlex ORCID
Early career · publishing since 2020Rising activity
Lymphoma Diagnosis and TreatmentCAR-T cell therapy researchChronic Lymphocytic Leukemia ResearchViral-associated cancers and disordersCNS Lymphoma Diagnosis and Treatment

Publications

57

Citations

254

Est. group size

~14

Recurring co-author estimate

Active years

7

Publishing since 2020

Research summary
AI-generated

Kaitlin Annunzio's research focuses on treatments for B-cell lymphomas, including CAR-T cell therapy (a treatment that engineers a patient's own immune cells to attack cancer) and bispecific antibodies (drugs that bind cancer cells and immune cells together to trigger an attack). Much of the work involves large, multicenter real-world studies examining outcomes, safety, and risk factors across different lymphoma subtypes and patient populations, such as older adults and those with central nervous system involvement.

CAR-T cell therapyB-cell lymphoma treatment outcomesBispecific antibody therapyMarginal zone and follicular lymphomaMulticenter real-world clinical studies

Publication output rose sharply from 2020 to a peak in 2023, then has been gradually declining through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 10.6/year recently
1718192020: 1 publication202021: 3 publications212022: 8 publications222023: 22 publications22232024: 14 publications242025: 8 publications252026: 1 publication26
Recent publications
Publishes in
  • Blood×22
  • Blood Advances×8
  • Journal of Clinical Oncology×7
  • Hematological Oncology×4
  • Journal of Hematology & Oncology×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile